Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson’s Disease

BACKGROUND: Parkinson’s disease (PD) patients are affected by hypokinetic dysarthria, characterized by hypophonia and dysprosody, which worsens with disease progression. Levodopa’s (l-dopa) effect on quality of speech is inconclusive; no data are currently available for late-stage PD (LSPD). OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabbri, Margherita, Guimarães, Isabel, Cardoso, Rita, Coelho, Miguel, Guedes, Leonor Correia, Rosa, Mario M., Godinho, Catarina, Abreu, Daisy, Gonçalves, Nilza, Antonini, Angelo, Ferreira, Joaquim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572389/
https://www.ncbi.nlm.nih.gov/pubmed/28878734
http://dx.doi.org/10.3389/fneur.2017.00432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572389/
https://www.ncbi.nlm.nih.gov/pubmed/28878734
http://dx.doi.org/10.3389/fneur.2017.00432

Ejemplares similares